From these data, we speculate that elevating levels of GLP-1 in patients with MetS suggest the presence of systemic hyper GLP -1 concentration-induced "GLP-1 resistance" or "GLP-1 dysfunction" in those patients like as insulin resistance or leptin resistance (Figure 3). The gene discussed is GCG; the disease is Insulin resistance.